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ABSTRACT 
 
          Subjective tinnitus is commonly experienced, especially by those with hearing loss.  
It is generally agreed that neural plasticity underlies the pathophysiology of subjective 
tinnitus.  Studies from audiology/hearing research and cognitive 
neuroscience/neuropsychology are reviewed to illuminate current understanding of the 
pathophysiology of tinnitus.  Research has revealed hyperactivity (increased spontaneous 
firing rate) in the dorsal cochlear nucleus, inferior colliculus, and other locations in the 
auditory system.  Reduced inhibition related to sensory deprivation at the cochlear level 
is thought to underlie hyperactivity in auditory structures.  Increased neural synchrony is 
also noted, and may be a correlate of hyperactivity.  Reorganization of cortical tonotopic 
maps is seen in subjective tinnitus, as is reorganization of visual and somatosensory 
cortical maps with sensory deprivation in those modalities.  Non-classical pathways 
branching from the inferior colliculus and thalamus to the amygdala may be involved in 
bothersome tinnitus.  Providing evidence-based practice for the treatment of subjective 
tinnitus remains challenging.  Current and emerging treatments are reviewed and 
recommendations for best practice based on research and clinical trial outcomes are 
discussed. 
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Chapter 1 
INTRODUCTION 
     Tinnitus is the perception of sound in the absence of an external acoustic stimulus.  
Speech or music that is perceived in the absence of an external stimulus is termed 
‘auditory hallucination’ and is distinct from tinnitus.  Tinnitus may be divided into two 
broad categories: objective and subjective.  Objective tinnitus is caused by an internal 
sound which becomes audible, such as turbulent blood flow or muscle contractions.  
Alternately it may be defined as a sound which is audible to the person and an observer.  
Subjective tinnitus is the phantom perception of sounds.  These sounds are generally 
characterized as a ringing, roaring, buzzing, hissing, or clicking.  Subjective tinnitus is 
much more common than objective tinnitus.  This paper focuses on subjective tinnitus, 
especially the relationship between cochlear damage (such as due to hearing loss, noise 
exposure, or ototoxic medication) and tinnitus.  Taking into account recent and classical 
research from audiology/hearing research and cognitive neuroscience disciplines, 
evidence based clinical practices regarding audiological management of patients with 
subjective tinnitus will be discussed.  
     It is estimated that 50 million people experience bothersome tinnitus, with 2.5 million 
of those people finding it debilitating in their lives (Davis & Rafaie, 2000).  The causes of 
tinnitus and its effective treatment remain nebulous for many patients and clinicians, with 
patients in many cases unsure of where to turn to for help. As a hearing specialist, an 
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audiologist is the logical professional to turn to for a patient hearing an obtrusive 
phantom sound.  The scope of practice of an audiologist allows one to “evaluate, 
diagnose, develop management strategies, and provide treatment and rehabilitation for 
tinnitus patients” (American Academy of Audiology, 2001).  In order for an audiologist 
to do this, they must take into consideration not only the ears but also the brain.  
Providing state-of-the-art evidence-based-practice for patients with subjective tinnitus is 
a challenge and requires a mastery of the current state of knowledge on the subject.  In 
order to best judge potential treatments it is necessary to understand current theories of 
the pathophysiology of subjective tinnitus as well as clinical trial outcomes for specific 
treatments or therapies. Understanding current theories and the evidence for them can be 
helped by considering other scientific disciplines such as cognitive neuroscience. 
     Audiology and cognitive neuroscience look at subjective tinnitus from two different 
perspectives.  Clinical audiologists wonder how best to prevent, differentiate, diagnose, 
and treat tinnitus.  Hearing researchers wonder what tinnitus tells us about the physiology 
of the auditory system and how we hear.  Cognitive neuroscience researchers wonder 
how the brain reorganizes when deprived of sensory input, and how this relates to the 
perception of real and phantom sensations and conscious experience.  An 
interdisciplinary view helps each discipline to create a more complete and useful model 
of subjective tinnitus, as each provides a different piece of a yet unsolved puzzle. 
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     Evidence for a central cause of subjective tinnitus is shown by studies of VIIIth nerve 
severance or labyrinthectomy.  Patients with tinnitus prior to removal of input from the 
ear usually still have it afterward, and some who did not have it previously will develop it 
after the surgery (Andersson, Kinnefors, Elkvall & Anderson, 1997). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 3
  
Chapter 2 
NEURAL PLASTICITY 
      Neural plasticity is the ability of the nervous system to change, and it happens from 
development through adulthood.  Neural plasticity as reorganization of cortical sensory 
maps has been shown in adult primates in somatosensory, visual, and auditory modes.  
Somatotopic representation of skin receptors is clearly organized (representation of 
adjacent areas on the body is reproduced in the mapping of sensory cortex) and relatively 
accessible, making it a logical place for studies of cortical plasticity.  When sensory input 
from half of the hand of a monkey was removed by severing the median nerve, an area 
formerly devoted to that part of the hand in the sensory cortex became innervated by 
neighboring areas.  The result was that the other parts of the hand became more sensitive, 
as shown by the development of a greater number of smaller receptive fields (stimulus 
region causing maximal response in a neuron) in those areas. Similar effects occurred 
when a single digit was amputated in owl monkeys (Kaas, 1991). 
     In the visual system, retinotopic representation preserves the relationship of 
neighboring areas in the visual field projected onto the retina.  The receptive field for a 
neuron early in the visual path corresponds to a narrowly defined area in the visual 
world.  It was found that when an area on the retina was lesioned, the size of the receptive 
fields of adjacent neurons quickly changed.  Another interesting discovery was that 
 4
although areas in the cortex formerly devoted to the lesioned spot began to process input 
from neighboring areas; the area corresponding to the lesion remained “silent” in the 
lateral geniculate nucleus, which is the thalamic relay for visual input (Gilbert & Wiesel, 
1990).  This phenomenon of cortex showing plasticity (with regard to neighboring areas 
taking over “abandoned real estate”) but not subcortical areas has been shown in the 
human central auditory system as well (Langers, van Dijk & Backes, 2005).  This has 
important implications for the relative extent of changes possible at different levels in 
sensory hierarchies, as well as similarities in sensory representations of different 
modalities.  
     Loss of input to neurons promotes plasticity, as the somatosensory and visual studies 
described above demonstrate.  Information about the human perception of the results of 
plasticity in the wake of stimulus deprivation can be gleaned from cases of phantom limb 
sensations.  Evidence that somatosensory cortex reorganization takes place in humans as 
in the animal research is shown in the case studies of amputees made by Vilayanur 
Ramachandran.  In somatosensory cortex, representation of the face lies next to 
representation of the hand and forearm, as shown in Figure 1.  One young man who had 
recently had his forearm amputated reported feeling his phantom hand being stroked 
when a Q-tip was lightly brushed across his face.  This “face-hand” was well defined and 
stable over successive trials.  Ramachandran reports that 3 of 7 forearm amputees showed 
a similar phenomenon (Ramachandran, 1993).  He has reported similar experiences for 
lower limb amputations and sexual stimulation, with one amputee reporting a 
magnification of orgasm experienced in his phantom foot (in the somatosensory map, the 
region corresponding to genital stimulation lies below that for the foot, see Figure 1).  
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Although demonstrating evidence for perceptual correlates of somatotopic cortical 
reorganization, the complex nature of hearing loss in the auditory periphery is very 
different from amputation and may make generalization from “phantom limbs” to 
“phantom sounds” untenable, except perhaps for cases of cochlear ablation or severing of 
the VIIIth nerve.  However, it does show that animal model experiments are relevant to 
human experience and lends insight into human conscious perception of phantom 
phenomena. Central neuropathic pain (pain that occurs in the absence of pain receptor 
stimulation) and tinnitus are considered more similar, and highly analogous ( Møller 
2007a) 
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.  
Fig. 1.1: The Penfield homunculus showing mapping of inputs to primary somatosensory 
cortex.  From Ramachandran (1993).      
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 In a demonstration of a differently motivated cortical change, owl monkeys taught a tone 
discrimination task for tones around 2.5 kHz showed increased cortical representation of 
those frequencies in primary auditory cortex compared to controls (Recanzone, Schreiner 
& Merzenich, 1993).  Similar results have been shown via magnetoencephalography 
(MEG) in somatosensory representation of fingers of violinists’ plucking (left) hands and 
via functional magnetic resonance imaging (fMRI) in non-musician adults trained in a 
finger manipulation task where subjects were taught to touch their thumb to different 
fingers on the same hand in a specified order (Elbert, Pantev, Wienbruch, Rockstroh & 
Taub, 1995; Karni et al., 1995).  Auditory discrimination therapy (ADT) is designed to 
change cortical representation of frequencies using a similar task so that areas for over-
represented tones which may be responsible for tinnitus perceptions are diminished while 
area for “trained” frequencies is increased (Herraiz, Diges & Cobo, 2007).  The 
correlation between perceived tinnitus pitch and input-deprived frequency representation 
in auditory cortex is not understood well enough to precisely determine the training 
frequencies, and research is underway to determine the optimal training frequencies for a 
given tinnitus pitch.  These types of therapies, rooted in current theories of 
neuroplasticity, show promise and may evolve to become powerful tools that help 
audiologists to treat tinnitus patients. 
NEURAL PLASTICITY AND THE AUDITORY SYSTEM 
     Neural plasticity can be effected through changes at the level of the synapse, creation 
or elimination of synapses, dendritic sprouting or pruning, and axon growth or death 
(Møller, 2007b).  Neural plasticity has been revealed in cortical and subcortical levels of 
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the auditory system, primarily in the dorsal cochlear nucleus, inferior colliculus, and 
auditory cortex.  Plastic changes commonly reported are hyperactivity (rise in 
spontaneous neural firing rate) and increased synchrony in neural firing and 
reorganization of cortical tonotopic maps.  Other reorganization may involve redirection 
of information to neighboring, non-auditory areas of the brain, such as the limbic system, 
and strengthening of the extralemniscal (non-classical) pathways.    
     The dorsal cochlear nucleus (DCN) is directly innervated by the ipsilateral auditory 
nerve (as is the ventral cochlear nucleus); a loss of stimulation due to a damaged cochlea 
first affects this structure.  This is the lowest level in the auditory system where 
hyperactivity related to tinnitus has been found, and both hyperactivity in the DCN and 
tinnitus have been shown to develop following outer hair cell injury in the cochlea and to 
persist following severing the VIIIth nerve (Kaltenbach, Zhang & Finlayson, 2005).  
Changes in pitch and loudness in tinnitus over time are correlated with changes in 
magnitude and frequency location in tonotopic organization of hyperactivity in the DCN 
(Kaltenbach, Zhang & Afman, 2000).  This higher spontaneous firing rate can be 
attributed to a reduction in inhibition related to loss of input at the cochlear level, and is 
shown in animal studies of several species whether the cochlear damage is due to hearing 
loss caused by noise or ototoxic substances.   
     Above the level of the DCN, multiple parallel pathways ascend and all ascending 
auditory pathways converge onto the inferior colliculus, which receives information from 
both ears.  The inferior colliculus (IC) neurons project to the medial geniculate nucleus of 
the thalamus, and also to other areas such as the superior colliculus where auditory and 
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visual information is integrated, and the cerebellum.  Tinnitus related changes (increased 
spontaneous firing rate and increased neural synchrony) have been widely documented in 
the IC.  A study in the chinchilla showed identical changes in a subpopulation of neurons 
in the IC whether cochlear trauma was due noise damage causing sparse inner hair cell 
(IHC) and sparse outer hair cell (OHC) loss, cisplatin causing mostly OHC loss with 
sparse IHC loss, or carboplatin causing pronounced IHC loss and no OHC loss (Bauer et 
al., 2008).  All three groups showed behavioral psychophysical evidence of chronic 
tinnitus resembling a 1000 Hz tone following cochlear damage.  In all three groups the 
largest change compared to controls was a subpopulation of neurons distributed 
throughout the IC that showed three characteristic features. A multidimensional analysis 
of multiple single unit recordings of the spontaneous activity showed high bursting 
(hyperexcitability), low interspike interval variance (increased synchrony), and within-
burst peak spiking of approximately 1000 per second.  This study concluded that the 
same underlying correlates of tinnitus appeared regardless of the type of cochlear trauma, 
and identified changes that occurred in all three groups.   
     Reorganization in auditory cortex is the third correlate of subjective tinnitus.  In 
humans, this is largely explored via MEG and shows that neurons in primary auditory 
cortex that are deprived of input become sensitive to frequencies neighboring those that 
were lost.  Frequencies neighboring the area of lost input become larger, while areas 
corresponding to lost frequencies shrink resulting in a distorted cortical tonotopic map 
(Eggermont, 2007).  Changes in cortical maps are correlated with perceived strength of 
tinnitus rather than peripheral hearing loss and appear to have much in common with 
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somatosensory cortical map changes and phantom limb sensations (Muhlnickel, Elbert, 
Taub & Flor, 1998).   
     Some people with subjective tinnitus find the tinnitus particularly bothersome or even 
debilitating, while others do not.  One theory that attempts to explain why this happens 
involves reorganization, not just in the auditory system, but in other regions as well.  
Auditory information ascends from ear to cortex via two pathways, the 
classical/lemniscal pathway and the non-classical/extralemniscal pathway.  The non-
classical pathway projects from the external nucleus and dorsal cortex of the IC to the 
dorsal and medial thalamic nuclei, and responds to more than auditory stimuli (multi-
modal).  Dorsal and medial thalamic nuclei are implicated in neuropathic pain as well as 
some forms of severe tinnitus (Møller, 2007a).  The multi-modal nature of this pathway 
may explain why many forms of tinnitus involve a tinnitus perception that changes with 
somatic manipulation such as neck tension or eye movement, and why tinnitus is 
associated with temporomandibular joint (TMJ) problems.  From the dorsal and medial 
thalamic nuclei the pathway continues to the auditory association cortex, bypassing the 
primary auditory cortex.  There is also a subcortical connection from the dorsal thalamus 
to the lateral nucleus of the amygdala.  The amygdala is located in the medial temporal 
lobe by the hippocampus and is implicated in implicit fear/aversive conditioning.  It 
receives sensory information from two pathways, the subcortical pathway just described 
(the “Low Route”) and a second pathway which goes from the thalamus to primary 
sensory cortex and then to the amygdala (the “High Route”, see Figure 2).  This allows 
threat analysis to be both fast and sure, with the subcortical pathway being the fast one.  
The amygdala mediates unconscious emotional response to aversive stimuli and also 
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interacts with memory systems to enhance memory for aversive emotional events, real or 
imagined.  It may be that a peripheral hearing loss leads to a lessening of inhibition 
resulting in high spontaneous firing rates in auditory pathways including the non-classical 
pathway leading to involvement of the amygdale and labeling of the percept of tinnitus as 
aversive. 
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 Fig. 1.2:  Illustration of the “High Route” and “Low Route” of sensory information to the 
lateral nucleus of the amygdale.  AL: lateral nucleus of the amygdala; ABL: basolateral 
nucleus of the amygdala; ACE: central nucleus of the amygdala; MGB: medial geniculate 
body; AI: primary auditory cortex, AII: association auditory cortex.  From Møller (2007) 
after LeDoux (1992).  
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 Chapter 3 
CURRENT AND EMERGING TINNITUS TREATMENTS 
     There are many potential avenues of treatment for tinnitus.  Pharmaceuticals (and 
herbal remedies, minerals, vitamins, etc.), electric/magnetic stimulation, hearing aids, 
cochlear implants, maskers/sound therapy, cognitive behavioral therapy/extinction 
training, neurofeedback, tinnitus retraining therapy, tinnitus activities therapy, auditory 
discrimination therapy, neuromonics treatment, and object identification and attention 
training have all been used with varying success. Currently, there is no “magic bullet” 
treatment which will definitely help any given patient with tinnitus, and no treatment 
permanently removes the tinnitus percept.  Problems for clinicians include: poorly 
understood pathophysiology of tinnitus, lack of diagnostic methods to clearly divide 
patients into clinically relevant subgroups, lack of gold-standard clinical trials, lack of 
pre-clinical trials to potentially introduce new and effective treatments, and lack of 
standardization of outcome measures to compare research and clinical trial outcomes.  
Despite these problems, recent breakthroughs in tinnitus research show promise for 
refinement of existing treatments and development of new ones. 
PHARMACEUTICAL TREATMENTS 
     Pharmaceutical treatments for tinnitus may be delivered systemically (usually orally) 
or via intratympanic injection. There are many drugs that have been administered in an 
attempt to provide tinnitus relief, but many (even the most commonly administered) lack 
formal clinical trials.  Optimally, a clinical trial is randomized, placebo-controlled, and 
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double blinded (RCTdouble).  This means that the subjects are randomly assigned to 
treatment groups, one of the groups is given a placebo treatment, and the investigator and 
subjects are unaware of which groups are which from the beginning to the end of the 
study.  This prevents allocation bias by the investigator (“cherry picking” subjects for 
certain treatment groups) and bias in assessment of outcomes by the investigator and 
subjects (allowing knowledge of whether the subject received placebo or treatment to 
bias reporting of effects of the treatment).  Some clinical trials are randomized, placebo-
controlled, and single-blinded (RCTsingle); in these trials the subjects do not know which 
group they have been assigned to but the investigator does.  The problem of subgroups of 
tinnitus types emerges to cloud reporting of results in clinical trials.  It may be that a 
given drug treatment is very effective for a certain subpopulation of tinnitus subjects, but 
if this subgroup is not isolated for study the treatment may fail to show significant 
efficacy or show reduced efficacy.  Currently there are not standard subgroupings of 
subjective tinnitus types, partially due to the poorly understood physiology of the 
phenomenon, but some that have been suggested are Meniere’s related tinnitus and 
tinnitus that can be physically modulated (changes when body or eye position is varied, 
or when the skin is stimulated).  This is because the tinnitus reported for Meniere’s 
patients is fairly unique, and is one of three symptoms that defines the disease.  It is 
hypothesized that tinnitus that changes in combination with somatosensory modulation 
may involve maladaptive changes in the non-classical auditory pathways and related 
areas.  Another postulated subgroup would divide subjective tinnitus patients according 
to whether the tinnitus is unilateral (heard in one ear) or either central or bilateral (heard 
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in both ears or in the head) as there is some evidence that these are different types of 
tinnitus (Ochi, Ohashi & Kenmoshi, 2003). 
     Dexamethasone as a treatment for tinnitus in patients with unilateral Meniere’s disease 
has been investigated with a RCTdouble study, which found that tinnitus was relieved for 
48% of the patients when the steroid was delivered intratympanically (Garduno-Anaya, 
Couthino De Toledo, Hinojosa-Gonzalez, Pane-Pianese & Rios-Castaneda, 2005).  
Investigation of other steroids such as methylprednisolone (often used to treat sudden 
sensorineural hearing loss) have shown no significant effect compared to placebo 
(Slattery, Fisher, Iqbal, Friedman & Liu, 2005).  Diuretics are often used in Meniere’s 
treatment, but there is no clear evidence that they alleviate tinnitus. 
     Lidocaine is a local anesthetic and has been investigated in tinnitus treatment for many 
years.  Although many studies show that lidocaine can temporarily alleviate tinnitus, the 
effect is short-lived and there are no high quality clinical trials that might justify clinical 
use. 
     Benzodiazepines are GABAtypeA receptor agonists.  Gabba-aminobutyric acid 
(GABA) is an inhibitory transmitter that may be implicated in reduction of inhibition 
resulting in the hyperactivity in auditory system structures now commonly recognized as 
a correlate of subjective tinnitus (Eggermont, 2007).  Some studies have shown reversal 
of signs of hyperactivity in the DCN and IC in animal models (Szczepaniak & Møller, 
1995), but there is no clinical evidence for efficacy.  Benzodiazepine use has negative 
side effects such as a high potential for dependence and sedation.  There is insufficient 
evidence to support the use of more modern anti-depressants such as SSRIs (selective 
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serotonin reuptake inhibitor/serotonin-specific reuptake inhibitor) for the treatment of 
tinnitus, although a patient who is exhibiting potential signs of depression related to the 
tinnitus should be referred to a psychiatrist.  Anti-depressants have been shown to be 
helpful for tinnitus patients who are depressed (Robinson, 2007). 
     Anti-convulsant drugs have been investigated as a potential tool in tinnitus treatment.  
Most have unfortunate side effects at the dosages used to treat epilepsy, but have been 
explored at lower dosages in tinnitus treatment.  No studies in humans have as yet 
showed promise, although an animal model study showed carbamazepine to protect 
against tinnitus in a dose dependent fashion in rats with salicylate induced tinnitus 
(Darlington & Smith, 2007).  A RCTdouble showed gabapentin to have no significant 
effect on severity of tinnitus (Witsell, Hannley, Stinnet & Tucci, 2007).  The anti-
spasticity drug baclofen was found to cause withdrawal symptoms in some of the subjects 
but to be no better than placebo at reducing tinnitus (Darlington & Smith, 2007).  
     Acamprosate is a drug used to treat alcohol dependence.  It acts by increasing GABA 
and decreasing glutamate (an excitatory neurotransmitter) at NMDA receptors which is 
thought to decrease the hyperactivity seen in tinnitus.  It was shown in a RCTsingle study 
to be effective in relieving tinnitus (though not completely removing any tinnitus 
sensations except in 3 of 50 subjects) significantly compared to placebo, with 86.9% of 
subjects in the acamprosate group reporting lessening of tinnitus sensation, and 47.8% of 
those subjects reporting continued effects at 90 days post drug administration (Azevedo 
& Figueiredo, 2007).  Further clinical trials may reveal this drug to be of help in treating 
tinnitus. 
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     Many herbal remedies (such as gingko biloba), vitamin and mineral supplements, and 
antioxidants are marketed as tinnitus treatments.  A review of the literature fails to show 
any scientific or clinical support for these substances (Enrico, Sirca & Mereu, 2007).  
Because these substances may be taken in combination with other pharmaceuticals or at 
very high dosages by patients who consider them harmless, it is important to determine 
whether tinnitus patients are self medicating and whether their physician has cleared them 
to use these substances at the levels they are being used and in conjunction with any other 
medications they may be taking.  Patients do not need to be dissuaded from trying these 
alternative remedies (as long as there are no contraindications), as they may receive real 
benefit from the placebo effect. 
     In the future, as an effective pharmaceutical treatment continues to be sought, newer 
animal model methods which allow assessment of behavioral evidence of the percept of 
tinnitus can be used to screen new substances for pre-clinical trials.  These methods have 
not been exploited to the extent that they could be, but offer a cost effective way to screen 
many potential tinnitus reducing drugs prior to costly clinical trials, and hopefully 
audiologists will see more in the literature when keeping up with tinnitus research.  
Currently, there is little evidence to support the use of drug treatment by professionals 
involved in treating tinnitus, although new animal methods used in discovering new 
drugs and further trials on those drugs (and some that currently show promise) may 
change that. 
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SOUND THERAPIES 
     Sound therapies for tinnitus include hearing aids which supply appropriately amplified 
sound stimulation in the region of the hearing loss whenever sound in that frequency 
region is present in the environment, maskers which supply a constant sound and are 
worn as an ear-level device, and other sound generators which may be ear or table level 
and may provide broadband or narrowband noise, pre-recorded environmental sounds 
(such as the seashore or water running), or pleasant music.  Sound therapies are 
appropriate for tinnitus patients whether the tinnitus is bothersome or merely noticeable.  
As previously mentioned with Auditory Discrimination Therapy, there is not a simple 
correlation with attenuation of tinnitus and tinnitus pitch, and efforts to maximize 
masking of tinnitus with a similar pitch have been unsuccessful (M. Jastreboff, 2007).  
Sound therapy is an important area of knowledge for audiologists, especially as tinnitus 
and hearing loss are highly correlated and tend to co-occur (Sindhusake et al., 2003).  
Studies examining the effects of hearing aid use on tinnitus are often outdated, and 
cannot be compared to today’s nonlinear digital options for amplification (Del Bo & 
Ambrosetti, 2007).  One recent study showed significant tinnitus reduction for hearing 
aid or sound therapy users, with the added benefit for hearing aid users of improved 
hearing and communication (Folmer & Carroll, 2006).  Overall there is a need for high 
quality research to assist audiologists in providing evidence-based-practice in this 
important area, particularly in areas pertaining to programming the hearing aids.  It is not 
clear whether turning off noise reduction or increasing gain in frequencies corresponding 
to tinnitus perception would be helpful.  How best to use new hearing aid technologies 
such as the Zen program in the Widex  Mind 330 and 440 hearing aids should be 
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understood by audiologists treating tinnitus.  What we know about neural plasticity and 
effects of sensory deprivation further justify use of amplification for hearing loss.   
Hearing aids alone do not appear to be enough to significantly help patients with 
bothersome tinnitus as a primary complaint, but it is possible that hearing aids may act as 
a preventive measure for developing tinnitus, and possibly protect against non-
bothersome tinnitus becoming bothersome.  Additional research in this area would be 
illuminating.  As in many other areas of treatment, a diagnostic tool that categorizes 
patients in a clinically relevant manner and provides a standardized measure of treatment 
outcome would be most welcome.   
COUNSELING THERAPIES 
     Cognitive behavioral therapy is a short term course of therapy using cognitive 
restructuring of thoughts, relaxation, and controlled exposure to exacerbating symptoms 
to promote habituation.  No evidence shows clinically significant improvement when 
used in isolation, but it is often combined with other treatments (sound therapy or 
pharmaceutical treatment) with varying degrees of success (Martinez-Devesa, Waddell, 
Perera & Theodoulou, 2009).   Informational/educational counseling is included in 
treating patients with non-bothersome or bothersome tinnitus and it is considered 
essential just as it is when treating a patient with a hearing loss, but is not intended as a 
treatment for tinnitus per se. 
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MULTI-MODAL TREATMENTS 
     Tinnitus retraining therapy (TRT) is a clinical method for treating bothersome tinnitus 
based on a neurophysiological model similar to what is described in this paper (P. 
Jastreboff, 2007).  TRT uses a combination of counseling and sound therapy to 
recategorize the tinnitus stimulus as neutral rather than aversive, separate the concepts of 
the tinnitus sensation and distress, and allows the presence of the sound of tinnitus while 
reducing tinnitus related distress.  This method attempts to enable a tinnitus patient to 
habituate to the tinnitus sensation.  Habituation refers to learning to ignore a stimulus that 
has no meaning.  Most tinnitus patients, who experience tinnitus that is noticeable but not 
usually bothersome, are able to habituate to their tinnitus.  Jastreboff postulates three 
stages in the development of tinnitus, with a fourth stage taking place in bothersome 
tinnitus: generation of abnormal neural activity that causes the percept of the tinnitus, 
interpretation of the abnormal neural activity, and evaluation at higher central nervous 
system centers.  In bothersome tinnitus, there is sustained activity in non-auditory regions 
such as the limbic (emotional) system and sympathetic autonomic nervous system which 
causes the tinnitus to be evaluated as a negative stimulus (see Figure 3).  Coincidental 
classical conditioning is thought to play a role in the development of bothersome tinnitus, 
for example when a person is in a negative emotional state when they notice the tinnitus.  
Classical conditioning pertains to association of a stimulus that evokes a measurable 
response (the unconditioned stimulus, such as distress due to a negative emotional state) 
with a stimulus that does not (the conditioned stimulus, such as early tinnitus).  Paired 
presentation of the stimuli results in the measurable response to the unconditioned 
stimulus occurring upon presentation of the conditioned stimulus alone (tinnitus 
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perception alone is enough to evoke distress).  This model provides an explanation for 
why the non-classical pathway branch to the amygdala might become significantly active 
in bothersome tinnitus, and it offers a possible solution: just as conditioning sharpened 
negative response to tinnitus, conditioning can facilitate habituation to the tinnitus.  TRT 
utilizes counseling to help the patient re-categorize tinnitus as a neutral stimulus, and 
sound therapy to decrease the abnormal neural activity associated with the tinnitus.  
Many studies, including an independent randomized study, show TRT to be highly 
effective at alleviating the impact of tinnitus in patients with bothersome tinnitus (P. 
Jastreboff, 2007).  It is a treatment that requires a significant dedication of time and 
resources on the part of the clinician, and results, while long lasting, require months to 
years of treatment.  
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Fig. 2.1: Jastreboff tinnitus model.  A: first stage of tinnitus, peripheral disruption in 
normal function; B: abnormal neural activity perception; C: evaluation of tinnitus as a 
neutral stimulus in non-bothersome tinnitus (no involvement of limbic and autonomic 
system); D: bothersome tinnitus showing self-strengthening loops of neural activity 
involving higher level evaluative systems, the limbic system, and the autonomic system.  
From Jastreboff (2007). 
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Neuromonics Tinnitus Treatment combines use of a relaxing musical sound therapy that 
is tailored to the patient’s hearing loss (if applicable) and counseling and support in a two 
stage program of desensitization to bothersome tinnitus.  Neuromonics sound therapy is 
designed to interact with the tinnitus and the limbic system by allowing intermittent 
perception of tinnitus within a pleasant and relaxing music therapy.  Candidacy for this 
treatment is designed to allow a subgroup of patients with bothersome tinnitus who are 
likely to have a successful outcome.  This therapy is not appropriate for those with a 4 
frequency pure tone average greater than 50 dB HL in the better hearing ear, a level of 
tinnitus disturbance not clinically significant, or co-morbid issues such as cognitive 
impairment or psychosis too great to allow the ability to reliably perform test measures 
(Davis, Paki & Hanley, 2007).  The desired outcome of Neuromonics treatment is a rapid 
and profound decrease in severity of tinnitus and improvement in quality of life. The 
third round of clinical trials demonstrated that 91% of the subjects in the Neuromonics 
test group showed significantly reduced tinnitus impairment as measured on the Tinnitus 
Reaction Questionnaire (TRQ) within 6 months of treatment, with 80% reporting scores 
that were no longer clinically significant  (Davis et al., 2007).  Neuromonics incorporates 
many of the tenets of TRT, such as the physiological model, but takes less time and 
clinical resources to produce very impressive results for a subpopulation of patients who 
experience bothersome tinnitus. 
 
 
 
 24
OTHER TREATMENTS 
     Transcranial Magnetic Stimulation (TMS) is a noninvasive method that causes global 
excitement of a population of neurons in the brain.  Repetitive TMS (rTMS) refers to 
repeated treatments and can produce longer lasting changes. Currently it has been shown 
that TMS or rTMS can temporarily interrupt tinnitus perception (much like lidocaine) but 
that the effects are transitory (Kleinjung, Steffens, Londero & Langguth, 2007).  
Implanted electrodes in auditory cortex have been shown to be effective for some 
subjects with tinnitus but not a majority (De Ridder, De Mulder, Menovsky, Sunaert & 
Kovacs 2007), although this might be an area where a significant effect might be found 
for a subgroup of tinnitus patients with severe unilateral tinnitus.  Trans-electrical nerve 
stimulation (TENS) is a treatment sometimes successful for patients with neuropathic 
pain, and may show promise for patients with somatic-modifiable tinnitus, although 
reduction of tinnitus was only shown in 46% of patients chosen for the study due to 
suspected somatic-modifiable tinnitus (Herraiz, Toledano & Diges, 2007).  
     Auditory Discrimination Therapy (ADT) is mentioned in the introduction of this 
paper, and is designed to change cortical representation of frequencies using a similar 
task so that areas for over-represented tones which may be responsible for tinnitus 
perceptions are diminished while area for “trained” frequencies is increased.  Results of a 
controlled study showed that 40% of the subjects showed some tinnitus improvement 
(Herraiz, Diges & Cobo, 2007), where subjects included showed a tinnitus handicap in 
the mild to moderate range on the Tinnitus Handicap Inventory (THI).  It remains to be 
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seen whether a different protocol will yield more promising results for this tinnitus 
intervention. 
     Another training therapy for tinnitus is being developed to augment counseling and 
sound therapy via a take-home auditory training program using a stimulus-drill 
approach.  Object identification and attention training is designed to improve the ability 
to attend to relevant sounds while ignoring distractors by encouraging adaptive plasticity 
related changes in the ability to attend to real sounds while ignoring tinnitus percepts 
using Auditory Object Identification and Localization (AOIL) tasks (Searchfield, 
Morrison & Wise, 2007).  Only a small (n of 10) pilot study has been completed at this 
time, with results showing a reduction in minimal masking levels.  More research will be 
necessary to evaluate AOIL for clinical use. 
     New neurofeedback paradigms based on MEG research on tinnitus in humans are 
showing some promising results.  MEG measures the magnetic fields produced by 
electrical activity in the brain and reflect the synchronous activity of large populations of 
neurons.  It is somewhat similar to electroencephalography (EEG) (which measures 
electric fields at the scalp produced by electrical activity in the brain) but boasts a slightly 
better spatial resolution while preserving excellent temporal resolution.  Differences in 
MEG recordings from temporal regions in tinnitus patients compared to controls show 
characteristic changes which may be due to increased neural synchrony in the auditory 
system in tinnitus.  Specifically, slow waves in the delta range (0.5-4 Hz) are increased 
while alpha activity (8-12 Hz) is reduced (Dohrmann, Weisz, Schlee, Harmann & Ebert, 
2007).  Using (relatively inexpensive compared to MEG) EEG equipment, 21 subjects 
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with chronic but not severe tinnitus underwent a neurofeedback training program of ten 
30 minute sessions over four weeks.  Subjects who were able to learn to control their 
brainwaves showed a significant reduction in tinnitus.  One patient, who was particularly 
good at the neurofeedback training was able to achieve complete tinnitus relief.  Subjects 
who were unable to do the training did not benefit from the treatment while those who 
were able to modify both bands simultaneously showed an average tinnitus intensity 
reduction of 71% (Dohrmann et al., 2007).  Based on the results of this study, the 
emerging field of neurofeedback treatment is worth keeping an eye on, although there are 
no clinical trials at this time. 
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Chapter 4 
CONCLUSION 
     Providing state-of-the-art evidence-based-practice for subjective tinnitus is extremely 
challenging.  Although progress is being made, the pathophysiology of tinnitus is still 
poorly understood.  Many treatments lack evidence on which to base their use, especially 
pharmaceutical treatments.  It is unclear how best to divide tinnitus into clinically 
relevant subgroups, although it is generally agreed that this would be beneficial.  
Consistency in assessing patients and in measuring treatment outcomes is an urgent need 
in the field, and agreement on outcome measurements would greatly facilitate 
comparison across research and treatment studies.  Relevant animal models involving 
behavioral methods to assess tinnitus perception in animal subjects are underused, but 
show great promise for advancing our understanding of tinnitus and discovering potential 
drug treatments.   
     Recommendations for clinical treatment begin with keeping up to date on results of 
clinical trials or studies addressing clinical efficacy of new or existing treatments.  
Audiologists should be knowledgeable about developments in our understanding of the 
pathophysiology of tinnitus.  Audiologists should make external referrals to appropriate 
professionals when necessary.  Physician referrals ensure the patient is evaluated to rule 
out any treatable disease that may cause or contribute to tinnitus and check that any self-
medicating the patient is doing is not potentially harmful.  A psychiatrist can assess 
whether clinical anxiety or depression are present and prescribe psychoactive medication 
when appropriate.  Audiological evaluation should be performed to assess hearing loss.  
Other test measures such as tinnitus pitch matching, tinnitus loudness levels, minimal 
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masking levels, etc. may be used to characterize a patient’s tinnitus or as part of a 
treatment (as in Neuromonics). Hearing aids should be used to treat hearing loss, as this 
minimizes sensory deprivation at the periphery.  External sound sources may be 
beneficial for patients whose tinnitus is intermittently bothersome or distracting.  An 
evidence based (valid and reliable) tool such as the Tinnitus Reaction Questionnaire 
should be used to verify whether tinnitus is bothersome to the patient (and to what 
degree).  Luckily, there are evidence-based treatments for bothersome tinnitus that have 
been shown to be effective at reducing tinnitus distress.  TRT or Neuromonics are 
indicated for such patients.    
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